BUFMX
Price
$14.41
Change
+$0.08 (+0.56%)
Updated
Jun 22 closing price
Net Assets
111.43M
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

BUFMX vs VMGMX

BUFMX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
BUFMX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUFMX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. BUFMX (111M). VMGMX pays higher dividends than BUFMX: VMGMX (0.62) vs BUFMX (0.00). BUFMX was incepted earlier than VMGMX: BUFMX (25 years) vs VMGMX (15 years). BUFMX (1.01) is less costly to investors than VMGMX (0.07). VMGMX is a more actively managed with annual turnover of: 17.00 vs. BUFMX (13.00). BUFMX has a lower initial minimum investment than VMGMX: BUFMX (2500) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 11.76 vs. BUFMX (-13.83). VMGMX return over 5 years is better than : 31.10 vs. BUFMX (-32.69).
BUFMXVMGMXBUFMX / VMGMX
Total Expense Ratio1.010.071,443%
Annual Report Gross Expense Ratio1.010.071,443%
Fund Existence25 years15 years-
Gain YTD-1.5129.952-15%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets111M33.8B0%
Annual Yield % from dividends0.000.62-
Returns for 1 year-13.8311.76-118%
Returns for 3 years-7.0155.53-13%
Returns for 5 years-32.6931.10-105%
Returns for 10 years-2.98213.13-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4